Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa

被引:7
作者
Kussmann, Manuel [1 ]
Hauer, Stefan [1 ]
Pichler, Petra [2 ]
Reznicek, Gottfried [3 ]
Burgmann, Heinz [1 ]
Poeppl, Wolfgang [1 ,4 ]
Zeitlinger, Markus [5 ]
Wiesholzer, Martin [2 ]
机构
[1] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Internal Med 1, Vienna, Austria
[2] Karl Landsteiner Univ Hlth Sci, Univ Hosp St Poelten, Dept Internal Med 1, St Polten, Austria
[3] Univ Vienna, Dept Pharmacognosy, Vienna, Austria
[4] Austrian Armed Forces, Mil Med Cluster East, Vienna, Austria
[5] Med Univ Vienna, Dept Clin Pharmacol, Waehringerguertel 18-20, A-1090 Vienna, Austria
关键词
Antibiotics; Infection; Peritoneal dialysis solutions; Peritonitis; Time-kill curves; INTRAVENOUS FOSFOMYCIN; ANTIBIOTICS; INTRAPERITONEAL; CIPROFLOXACIN; DAPTOMYCIN; ERTAPENEM; OUTCOMES; PH;
D O I
10.1007/s10096-018-3221-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Peritonitis is still the main infectious complication among patients on peritoneal dialysis. For treatment of peritoneal dialysis-related peritonitis, the intraperitoneal administration of antibiotics admixed to peritoneal dialysis fluids (PDFs) should be preferred. However, the influence of diverse PDFs on the activity of frequently used antibiotics has been investigated insufficiently. Thus, the present study set out to investigate the in vitro activity of fosfomycin against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus epidermidis, and Staphylococcus aureus in commercially available PDFs. Time-kill curves in four different PDFs (DianealA (R), ExtranealA (R), NutrinealA (R), and PhysionealA (R)) were performed over 24 h with two different concentrations of fosfomycin (150 and 400 mg/L) and without antibiotics as control. Cation-adjusted Mueller Hinton broth (CA-MHB) was used as a comparator solution. In blank PDFs, bacterial growth of each organism evaluated was reduced when compared to CA-MHB. For S. aureus in blank PhysionealA (R), a reduction under the limit of detection was observed within 24 h. The activity of fosfomycin was reduced in all PDFs when compared to CA-MHB except for P. aeruginosa in NutrinealA (R) where the activity of fosfomycin was increased when investigated at 400 mg/L. Against E.coli, bactericidal activity was demonstrated in ExtranealA (R), NutrinealA (R), and PhysionealA (R). Fosfomycin resistance (MIC > 1024 mg/L) was observed for P. aeruginosa in CA-MHB at both concentrations and in NutrinealA (R) at 150 mg/L. Fosfomycin is active in PDFs particularly against the frequently isolated enterobacterium E. coli. The choice of the respective PDF considerably influences the microbiological outcome in vitro. Further studies are warranted to investigate the clinical relevance of these findings.
引用
收藏
页码:1091 / 1098
页数:8
相关论文
共 23 条
  • [11] Compatibility of fosfomycin with different commercial peritoneal dialysis solutions
    Kussmann, M.
    Baumann, A.
    Hauer, S.
    Pichler, P.
    Zeitlinger, M.
    Wiesholzer, M.
    Burgmann, H.
    Poeppl, W.
    Reznicek, G.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (11) : 2237 - 2242
  • [12] The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis
    Kussmann, M.
    Schuster, L.
    Zeitlinger, M.
    Pichler, P.
    Reznicek, G.
    Wiesholzer, M.
    Burgmann, H.
    Poeppl, W.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (11) : 2257 - 2263
  • [13] INFLUENCE OF DIFFERENT PERITONEAL DIALYSIS FLUIDS ON THE IN VITRO ACTIVITY OF CEFEPIME, CIPROFLOXACIN, ERTAPENEM, MEROPENEM AND TOBRAMYCIN AGAINST ESCHERICHIA COLI
    Kussmann, Manuel
    Schuster, Linda
    Wrenger, Sarah
    Pichler, Petra
    Reznicek, Gottfried
    Burgmann, Heinz
    Poeppl, Wolfgang
    Zeitlinger, Markus
    Wiesholzer, Martin
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2016, 36 (06): : 662 - 668
  • [14] ISPD PERITONITIS RECOMMENDATIONS: 2016 UPDATE ON PREVENTION AND TREATMENT
    Li, Philip Kam-Tao
    Szeto, Cheuk Chun
    Piraino, Beth
    de Arteaga, Javier
    Fan, Stanley
    Figueiredo, Ana E.
    Fish, Douglas N.
    Goffin, Eric
    Kim, Yong-Lim
    Salzer, William
    Struijk, Dirk G.
    Teitelbaum, Isaac
    Johnson, David W.
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2016, 36 (05): : 481 - 508
  • [15] Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis
    Ma, Terry King-Wing
    Leung, Chi Bon
    Chow, Kai Ming
    Kwan, Bonnie Ching-Ha
    Li, Philip Kam-Tao
    Szeto, Cheuk Chun
    [J]. CLINICAL KIDNEY JOURNAL, 2016, 9 (04): : 616 - 623
  • [16] EFFECT OF PERITONEAL-DIALYSIS FLUID AND PH ON BACTERICIDAL ACTIVITY OF CIPROFLOXACIN
    MCCORMICK, EM
    ECHOLS, RM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) : 657 - 659
  • [17] Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts
    Mujais, S.
    Story, K.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 : S21 - S26
  • [18] SCHLESSINGER D, 1988, Clinical Microbiology Reviews, V1, P54
  • [19] INVITRO ANTIBACTERIAL ACTIVITIES OF ANTIBIOTICS AGAINST PSEUDOMONAS-AERUGINOSA IN PERITONEAL-DIALYSIS FLUID
    SHALIT, I
    WELCH, DF
    JOAQUIN, VHS
    MARKS, MI
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (06) : 908 - 911
  • [20] Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids
    Tobudic, S.
    Poeppl, W.
    Kratzer, C.
    Vychytil, A.
    Burgmann, H.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (07) : 1327 - 1334